Exhibit 99.2
Filed by Aviragen Therapeutics, Inc.
Pursuant to Rule 425 under the Securities Act of 1933, as amended
And deemed filed pursuant to Rule 14a-12
Of the Securities Exchange Act of 1934, as amended
Subject Company: Aviragen Therapeutics, Inc.
Commission File No. for Registration
Statement on Form S-4: 333-222009
